[1] The mechanism likely involves the extract traveling down the gastrointestinal tract as a high-concentration bolus, triggering hormones along the way
"That leads to indiscriminate use by individuals who are not clinically obese." She added that because most patients lose weight only while actively taking the drug, long-term use is often required
Unlike IGF-1 DES, which benefits from site-specific injection, LR3's long half-life means injection site matters less, the peptide will circulate systemically regardless of where you inject it
They reinforce each other
Meanwhile, gyms and supplement companies have marketed to these concerns, while influencers frame muscle loss as inherently dangerous, Dr
The UK SmPC includes a warning about thyroid C-cell tumours observed in rodent studies and advises monitoring for symptoms such as a neck mass, dysphagia, dyspnoea, or persistent hoarseness